All In MedTech

Device Trial Radar · NCT07911566

Safety and Efficacy of the Fully Closed Loop iLet Bionic Pancreas in Adults With Type 1 and Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Beta Bionics, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Castor EDC
First posted
Nov 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the safety and efficacy of the fully closed loop (FCL) iLet automated insulin delivery (AID) System in people ≥18 years old with type 1 diabetes or type 2 diabetes requiring insulin therapy. The main questions it aims to answer are: Do HbA1c levels decrease when using the iLet FCL algorithm? What medical problems do participants have when using the iLet FCL algorithm? Participants will use the iLet FCL for 13 weeks, undergo bloodwork, and complete psychosocial questionnaires.

Conditions

  • Diabetes (Insulin-requiring, Type 1 or Type 2)

Interventions

  • iLet FCLDevice

    iLet FCL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HbA1c change from baselineTime frame: 13 weeks
  2. Rate of severe hypoglycemia requiring assistance to actively administer treatmentTime frame: 13 weeks
  3. Rate of severe hypoglycemia resulting in seizure/loss of consciousnessTime frame: 13 weeks

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.